Business

mass. movers

Repligen’s revenue slides 18.2 percent

For fiscal 2014, Repligen sees $54 million to $57 million in revenue and net income of $7 million to $9 million.

New York Times/File 2006

For fiscal 2014, Repligen sees $54 million to $57 million in revenue and net income of $7 million to $9 million.

Advertisement

Waltham-based Repligen Corp., which produces products used in the manufacturing of biological drugs, reported quarterly revenue of $15.4 million, an 18.2 percent decrease from the year-earlier quarter, as adjusted earnings per share fell to 10 cents from 30 cents. Wall Street estimates had called for $15.9 million in revenue and 14 cents in per-share earnings. If there was a bright spot, Motley Fool reported, it was that bioprocessing revenue jumped nearly 7 percent to $10.4 million.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com